GENERAL AMERICAN INVESTORS CO INC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
GENERAL AMERICAN INVESTORS CO INC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2020$1,080,000
-81.9%
600,000
-15.8%
0.12%
-83.5%
Q2 2020$5,977,000
+60.1%
712,4000.0%0.76%
+50.1%
Q1 2020$3,733,000
+8.1%
712,400
+12.7%
0.50%
+59.8%
Q4 2019$3,453,000
+27.2%
632,400
+13.5%
0.32%
+17.9%
Q3 2019$2,715,000
-29.7%
557,4000.0%0.27%
-26.8%
Q2 2019$3,863,000
-0.3%
557,4000.0%0.37%
-4.7%
Q1 2019$3,874,000557,4000.38%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$3,107,0001.71%
ETF MANAGERS GROUP, LLC 14,138,998$8,534,0000.17%
Ikarian Capital, LLC 948,526$584,0000.09%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 318,668$196,0000.03%
Platform Technology Partners 45,000$28,0000.01%
XTX Topco Ltd 34,476$21,0000.01%
PINNACLE ASSOCIATES LTD 947,083$583,0000.01%
Penserra Capital Management LLC 537,236$330,0000.01%
Mirae Asset Global Investments Co., Ltd. 4,070,006$2,506,0000.01%
Tekla Capital Management LLC 154,310$95,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders